Please login to the form below

Not currently logged in
Email:
Password:

pharma takeover

This page shows the latest pharma takeover news and features for those working in and with pharma, biotech and healthcare.

Shire rebuffs Takeda bids, as Allergan bows out

Shire rebuffs Takeda bids, as Allergan bows out

It said Shire shareholders would own 51% of the merged company after the takeover. ... Shire was recently tipped as the next big pharma takeover, in part because of pipeline troubles and its share price has been depressed following its $36bn takeover of

Latest news

  • Takeda mulls bid for Irish biopharma Shire Takeda mulls bid for Irish biopharma Shire

    Takeda mulls bid for Irish biopharma Shire. The Japanese pharma firm must make a formal offer by 25 April. ... pharma takeover after AbbVie’s failed takeover bid in 2014.

  • Shire suffers pipeline failure as takeover speculation builds Shire suffers pipeline failure as takeover speculation builds

    Shire suffers pipeline failure as takeover speculation builds. Several big pharma companies are reportedly considering bids. ... pharma takeover – if City rumour-mongers are to be believed.

  • Gilead makes $11.9bn play for CAR-T specialist Kite Gilead makes $11.9bn play for CAR-T specialist Kite

    makes it Gilead's largest takeover since it bought Pharmasset for $11bn in 2011 to bolt on its HCV franchise. ... will reach the market at a time when scrutiny of pharma pricing is arguably higher than ever before.

  • Stada's €4.1bn takeover goes through Stada's €4.1bn takeover goes through

    Stada's 4.1bn takeover goes through. German pharma company finally comes under new ownership. ... After months of wrangling, German pharma company Stada has finally come under new ownership after a successful tender by private equity firms Bain and Cinven

  • Quantum Pharma confirms Clinigen takeover bid Quantum Pharma confirms Clinigen takeover bid

    Quantum Pharma confirms Clinigen takeover bid. Clinigen has until September 13 to make a formal offer. ... Shares in UK drugmaker Quantum Pharma are rising fast after it revealed with was in takeover talks with larger rival Clinigen Group.

More from news
Approximately 28 fully matching, plus 33 partially matching documents found.

Latest Intelligence

  • Pharma deals during July 2013 Pharma deals during July 2013

    Pharma deals during July 2013. Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month. ... Elan's saga finally ends. We watched with great interest as Elan battled against the $6.7bn, increasing to $8bn, hostile takeover

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Senior AstraZeneca exec jumps ship to small biotech Senior AstraZeneca exec jumps ship to small biotech

    He will leave the world's eight largest pharma firm to join a much smaller, privately owned biotech company, whose identity has not yet been publicly revealed. ... 12 months ago the firm successfully rejected an $118bn takeover attempt from the US

  • Kite Pharma names Cynthia Butitta as CFO Kite Pharma names Cynthia Butitta as CFO

    Kite Pharma names Cynthia Butitta as CFO. She helped broker Pfizer’ s takeover of NextWave Pharmaceuticals. ... She was also VP of finance at the biotech Connetics. Kite Pharma is a biotech specialist in the burgeoning area of cancer immunotherapy

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics